Search results

Selected filters:

North America
Valuation

Article type

Topic

Sector

Jurisdictions

220 results found for your search

Sort options
06 December 2019

Chinese memory upstart secures DRAM patents in hybrid deal with WiLAN

CXMT picks up former Qimonda rights at a time when Beijing government is prioritising creation of national champions

05 December 2019

Auto IP stakeholders in Asia call for peace, prepare for war

Huawei, Nokia and top Japanese brands discussed the licensing conflicts confronting the industry in front of a packed room in Shanghai

05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

29 November 2019

The 2019 brokered patent market from the buyer and seller perspective

Asking prices for patents are up from last year. However, the size of the market is down and assertion activity from NPEs may be on the rise

29 November 2019

The 2019 brokered patent market

Richardson Oliver Insights highlights a shrinking market, but rising asset prices in its annual breakdown of the deals landscape

28 November 2019

Apple’s IP chief takes top place in this year’s <em>IAM</em> Market Makers list

Jeff Myers heads the 40-strong selection of the global dealmaking elite thanks in no small part to the iPhone giant’s huge Intel patent play in the summer

19 November 2019

Second listing sees Alibaba on firmer IP footing

The e-commerce giant prices its Hong Kong offering this week. Five years after its NYSE debut, it has a more formidable patent portfolio and new IP-based alliances

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

05 November 2019

TSMC chief speaks as market reacts to foundry war settlement

Exact terms remain confidential, but TSMC's CEO suggested to employees that the licence rights are not transferrable should Globalfoundries be acquired

25 October 2019

GlobalFoundries’ patent attack on TSMC may have come too late  

In-depth analysis shows that the Taiwanese semiconductor business has not only bulked up its portfolio over the last decade, but also considerably improved its quality

09 October 2019

IBM has the world's most valuable patent portfolio, new analysis claims

Samsung, Canon, Microsoft and Bosch round-out the top five who, between them, are said to own assets worth well in excess of $35 billion

04 October 2019

The new China dynamic, pool progress and more from our Patent Licensing event

The big takeaways from a day of deal-making discussions in the heart of Silicon Valley

27 September 2019

Before IBM arrived, building a patent deterrent meant plenty of deals for Red Hat

In an exclusive interview, the company's IP head reveals that in the run-up to its acquisition by Big Blue the open source leader went shopping at a range of companies include AT&T, Huawei and Panasonic

23 September 2019

Nanjing judge sets Chinese SEP rate in dispute between Conversant and Huawei

Chinese court has had its say on royalties - and it looks like the telecoms giant has got exactly what it was looking for